194 related articles for article (PubMed ID: 35679877)
1. The Association of Lipids and Lipoproteins with Hip Fracture Risk: The Cardiovascular Health Study.
Barzilay JI; Buzkova P; Kuller LH; Cauley JA; Fink HA; Sheets K; Robbins JA; Carbone LD; Elam RE; Mukamal KJ
Am J Med; 2022 Sep; 135(9):1101-1108.e1. PubMed ID: 35679877
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
[TBL] [Abstract][Full Text] [Related]
3. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
[TBL] [Abstract][Full Text] [Related]
4. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.
Mora S; Otvos JD; Rifai N; Rosenson RS; Buring JE; Ridker PM
Circulation; 2009 Feb; 119(7):931-9. PubMed ID: 19204302
[TBL] [Abstract][Full Text] [Related]
6. Associations of lipoprotein subclasses with risk of all-cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study.
Li R; Chen JX; Lu Q; Geng TT; Xia PF; Wang Y; Chen LK; Shan ZL; Pan A; Liu G
Diabetes Obes Metab; 2023 Nov; 25(11):3259-3267. PubMed ID: 37492984
[TBL] [Abstract][Full Text] [Related]
7. Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease.
Kou M; Ding N; Ballew SH; Salameh MJ; Martin SS; Selvin E; Heiss G; Ballantyne CM; Matsushita K; Hoogeveen RC
Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1229-1238. PubMed ID: 33504178
[TBL] [Abstract][Full Text] [Related]
8. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
Lawler PR; Akinkuolie AO; Chu AY; Shah SH; Kraus WE; Craig D; Padmanabhan L; Glynn RJ; Ridker PM; Chasman DI; Mora S
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733430
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women.
Mora S; Otvos JD; Rosenson RS; Pradhan A; Buring JE; Ridker PM
Diabetes; 2010 May; 59(5):1153-60. PubMed ID: 20185808
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.
Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Kadota A; Kadowaki S; Kadowaki T; Yamamoto T; Miyagawa N; Zaid M; Torii S; Takashima N; Murakami Y; Okamura T; Horie M; Ueshima H;
Atherosclerosis; 2014 Oct; 236(2):237-43. PubMed ID: 25105580
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein Characteristics and Incident Coronary Heart Disease: Prospective Cohort of Nearly 90 000 Individuals in UK Biobank.
Jin D; Trichia E; Islam N; Bešević J; Lewington S; Lacey B
J Am Heart Assoc; 2023 Oct; 12(20):e029552. PubMed ID: 37815053
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
Lamprea-Montealegre JA; Staplin N; Herrington WG; Haynes R; Emberson J; Baigent C; de Boer IH;
Clin J Am Soc Nephrol; 2020 Jan; 15(1):47-60. PubMed ID: 31831577
[TBL] [Abstract][Full Text] [Related]
13. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
[TBL] [Abstract][Full Text] [Related]
14. Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study.
Greenlund KJ; Webber LS; Srinivasan S; Wattigney W; Johnson C; Berenson GS
Ann Epidemiol; 1997 Nov; 7(8):561-7. PubMed ID: 9408552
[TBL] [Abstract][Full Text] [Related]
15. Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.
Otvos JD; Guyton JR; Connelly MA; Akapame S; Bittner V; Kopecky SL; Lacy M; Marcovina SM; Muhlestein JB; Boden WE
J Clin Lipidol; 2018; 12(2):348-355.e2. PubMed ID: 29409728
[TBL] [Abstract][Full Text] [Related]
16. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
[TBL] [Abstract][Full Text] [Related]
17. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
Goff DC; D'Agostino RB; Haffner SM; Otvos JD
Metabolism; 2005 Feb; 54(2):264-70. PubMed ID: 15690322
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein profiles of fat distribution and its association with insulin sensitivity.
Wei D; Marrachelli VG; Melgarejo JD; Liao CT; Janssens S; Verhamme P; Vanassche T; Van Aelst L; Monleon D; Redón J; Zhang ZY
Front Endocrinol (Lausanne); 2022; 13():978745. PubMed ID: 36387872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
